John Arnold: Are pharmacy benefit managers the good guys or bad guys of drug pricing?
(By John Arnold for STAT) In the ongoing debate over drug prices, the pharmaceutical industry has been highly effective in
Read More(By John Arnold for STAT) In the ongoing debate over drug prices, the pharmaceutical industry has been highly effective in
Read More(ByChad Terhune for Kaiser Health News) Drew Calver took out his trash cans and then waved goodbye to his wife,
Read More(By Sally Welborn and Pramod John for STAT) Americans are divided on many fronts: tariffs, building walls, and how to
Read More(By Alex Leeds Matthews for California Healthline produced by Kaiser Health News) As prices for drugs and procedures soar, and
Read More(By Kelly Gooch and Ayla Ellison for Becker’s Hospital Review) CMS’ 2019 Medicare Outpatient Prospective Payment System proposed rule, which calls
Read MoreIn a letter of support for the Defense, Labor, Health and Human Services and Education Appropriations Act for 2019, or
Read More(By Alia Paavola for Becker’s Hospital Review) Brand-name combination drugs may be more expensive than buying each drug separately, and
Read MoreAccording to the American Hospital Association, hospitals have been closing at a rate of about 30 a year. For patients
Read More(By Alia Paavola for Becker’s Hospital Review) The pharmaceutical industry is facing increased pressure from President Donald Trump, lawmakers and
Read MoreMedicare Advantage plans will have the flexibility to target non-medical health-related services to those members who have chronic care conditions
Read More